BRAINLIFE.ORG

Current Neuro-Oncology

Volume 25 Number 12
30 June 2023

Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 12, 30 June

Bauman MMJ, Giesken MB, Naylor RM, Keating GF, Schwartz JD, Daniels DJ.
Predicting disease progression and the need for tumor-directed treatment in tectal plate gliomas.
J Neurosurg Pediatr. 2023 Jun 16:1-11∟. doi: 10.3171/2023.4.PEDS22485∟. PMID: 37347621∟. Observational study˰ ˍ

Ly KI, Richardson LG, Liu M, Muzikansky A, Cardona J, Lou K, Beers AL, Chang K, Brown JM, Ma X, Reardon DA, Arrillaga-Romany IC, Forst DA, Jordan JT, Lee EQ, Dietrich J, Nayak L, Wen PY, Chukwueke U, Giobbie-Hurder A, Choi BD, Batchelor TT, Kalpathy-Cramer J, Curry WT, Gerstner ER.
Bavituximab decreases immunosuppressive myeloid-derived suppressor cells in newly diagnosed glioblastoma patients.
Clin Cancer Res. 2023 Jun 16:CCR-23-0203∟. doi: 10.1158/1078-0432.CCR-23-0203∟. PMID: 37327319∟. Interventional study˰ ˍ

*

Massimino M, Vennarini S, Buttarelli FR, Antonelli M, Colombo F, Minasi S, Pecori E, Ferroli P, Giussani C, Schiariti M, Schiavello E, Biassoni V, Erbetta A, Chiapparini L, Nigro O, Boschetti L, Gianno F, Miele E, Modena P, De Cecco L, Pollo B, Barretta F.
Optimizing reirradiation for relapsed medulloblastoma: identifying the ideal patient and tumor profiles.
J Neurooncol. 2023 Jun 16∟. doi: 10.1007/s11060-023-04361-z∟. PMID: 37326761∟. Observational study˰ ˍ

Roux A, Aboubakr O, Elia A, Moiraghi A, Benevello C, Fathallah H, Parraga E, Oppenheim C, Chretien F, Dezamis E, Zanello M, Pallud J.
Carmustine wafer implantation for supratentorial glioblastomas, IDH-wildtype in "extreme" neurosurgical conditions.
Neurosurg Rev. 2023 Jun 17;46(1):140∟. doi: 10.1007/s10143-023-02052-x∟. PMID: 37329341∟. Observational study˰ ˍ

Tauziède-Espariat A, Métais A, Mariet C, Castel D, Grill J, Saffroy R, Hasty L, Dangouloff-Ros V, Boddaert N, Benichi S, Chrétien F, Varlet P.
The pontine diffuse midline glioma, EGFR-subtype with ependymal features: Yet another face of diffuse midline glioma, H3K27-altered.
Brain Pathol. 2023 Jun 18:e13181∟. doi: 10.1111/bpa.13181∟. PMID: 37331375∟. Case report. ˍ

Hänsch L, Peipp M, Mastall M, Villars D, Myburgh R, Silginer M, Weiss T, Gramatzki D, Vasella F, Manz MG, Weller M, Roth P.
Chimeric antigen receptor (CAR) T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma.
Neuro Oncol. 2023 Jun 19:noad108∟. doi: 10.1093/neuonc/noad108∟. PMID: 37335916∟. Laboratory investigation. ˍ

Kartal İ, Dağdemir A, Dinçer OS, Şimşek HK, Uygun A, Gürsel ŞB.
Treatment Outcomes of Childhood Medulloblastoma with the SIOP/UKCCSG PNET-3 Protocol.
Indian J Pediatr. 2023 Jun 19∟. doi: 10.1007/s12098-023-04675-w∟. PMID: 37335442∟. Observational study. ˍ

Ratliff M, Karimian-Jazi K, Hoffmann DC, Rauschenbach L, Simon M, Hai L, Mandelbaum H, Schubert MC, Kessler T, Uhlig S, Azorin DD, Jung E, Osswald M, Solecki G, Maros ME, Venkataramani V, Glas M, Etminan N, Scheffler B, Wick W, Winkler F.
Individual glioblastoma cells harbor both proliferative and invasive capabilities during tumor progression.
Neuro Oncol. 2023 Jun 19:noad109∟. doi: 10.1093/neuonc/noad109∟. PMID: 37335907∟. Laboratory investigation˰ ˍ

+*

Reijneveld JC, Machingura A, Coens C, Taphoorn MJB, Taal W, Clement PM, Idbaih A, de Vos FYF, Klein M, Wick W, Mulholland PJ, Lewis J, Golfinopoulos V, Ghislain I, Bottomley A, van den Bent MJ; EORTC Brain Tumor Group.
Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first-recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Treatment of Cancer 26091).
Eur J Cancer. 2023 Jun 19;190:112946∟. doi: 10.1016/j.ejca.2023.112946∟. PMID: 37453240∟. Interventional study. ˍ

Roder C, Stummer W, Coburger J, Scherer M, Haas P, von der Brelie C, Kamp MA, Löhr M, Hamisch CA, Skardelly M, Scholz T, Schipmann S, Rathert J, Brand CM, Pala A, Ernemann U, Stockhammer F, Gerlach R, Kremer P, Goldbrunner R, Ernestus RI, Sabel M, Rohde V, Tabatabai G, Martus P, Bisdas S, Ganslandt O, Unterberg A, Wirtz CR, Tatagiba M.
Intraoperative MRI-Guided Resection Is Not Superior to 5-Aminolevulinic Acid Guidance in Newly Diagnosed Glioblastoma: A Prospective Controlled Multicenter Clinical Trial.
J Clin Oncol. 2023 Jun 19:JCO2201862∟. doi: 10.1200/JCO.22.01862∟. PMID: 37335962∟. Interventional study. ˍ

*

Xiong M, Chen Z, Zhou C, Yang X, Hu W, Jiang Y, Zheng R, Fan W, Mou Y, Lin X.
PSMA PET/MR is a New Imaging Option for Identifying Glioma Recurrence and Predicting Prognosis.
Recent Pat Anticancer Drug Discov. 2023 Jun 19;19(3):383-395. doi: 10.2174/1574892818666230519150401. PMID: 38214322. Observational study˰ ˍ

*

Peng Y, Ren Y, Huang B, Tang J, Jv Y, Mao Q, Liu Y, Lei Y, Zhang Y.
A validated prognostic nomogram for patients with H3 K27M-mutant diffuse midline glioma.
Sci Rep. 2023 Jun 20;13(1):9970∟. doi: 10.1038/s41598-023-37078-0∟. PMID: 37340065∟. Observational study. ˍ

Wijnenga MMJ, Maas SLN, van Dis V, Tesileanu CMS, Kros JM, Dirven L, Hazelbag HM, Dubbink HJ, Vincent AJPE, French PJ, van den Bent MJ.
Glioblastoma lacking necrosis or vascular proliferations: Different clinical presentation but similar outcome, regardless of histology or isolated TERT promoter mutation.
Neurooncol Adv. 2023 Jun 21;5(1):vdad075∟. doi: 10.1093/noajnl/vdad075∟. PMID: 37441086∟. Observational study. ˍ

Kang Z, Li S, Kang X, Deng J, Yang H, Chen F, Jiang J, Zhang J, Li W.
Phase I study of chlorogenic acid injection for recurrent high-grade glioma with long-term follow-up.
Cancer Biol Med. 2023 Jun 22;20(6):465–76∟. doi: 10.20892/j.issn.2095-3941.2022.0762∟. PMID: 37366368∟. Interventional study. ˍ

Ma Q, Liu L, Sun N, Gao L, Chen Y, Liu L, Guo W, Yang X.
Glioblastoma with a primitive neuronal component: A case report.
Oncol Lett. 2023 Jun 22;26(2):341∟. doi: 10.3892/ol.2023.13927∟. PMID: 37427343∟. Case report. ˍ

Wang C, Cai Z, Huang Y, Liu X, Liu X, Chen F, Li W.
Honokiol in glioblastoma recurrence: a case report.
Front Neurol. 2023 Jun 22;14:1172860∟. doi: 10.3389/fneur.2023.1172860∟. PMID: 37426439∟. Case report. ˍ

Zheng J, Dong H, Li M, Lin X, Wang C.
Prediction of IDH1 gene mutation by a nomogram based on multiparametric and multiregional MR images.
Clinics (Sao Paulo). 2023 Jun 22;78:100238∟. doi: 10.1016/j.clinsp.2023.100238∟. PMID: 37354775∟. Observational study. ˍ

Achi J, Achi XW, Veintimilla P, Cueva J.
Unusual extraneural metastasis of glioblastoma.
Surg Neurol Int. 2023 Jun 23;14:218∟. doi: 10.25259/SNI_191_2023∟. PMID: 37404487∟. Case report. ˍ

*

Young JS, Al-Adli NN, Muster R, Chandra A, Morshed RA, Pereira MP, Chalif EJ, Hervey-Jumper SL, Theodosopoulos PV, McDermott MW, Berger MS, Aghi MK.
Does waiting for surgery matter? How time from diagnostic MRI to resection affects outcomes in newly diagnosed glioblastoma.
J Neurosurg. 2023 Jun 23:1-14∟. doi: 10.3171/2023.5.JNS23388∟. PMID: 37382331∟. Observational study˰ ˍ

Zemskova O, Pedachenko E, Yu NY, Rades D.
Hypo-fractionated Radiotherapy (HF-RT) Versus Conventionally Fractionated Radiotherapy (CF-RT) for Glioblastoma.
Anticancer Res. 2023 Jun 23;43(7):3121-3128∟. doi: 10.21873/anticanres.16484∟. PMID: 37351960∟. Observational study˰ ˍ

Adile AA, Bakhshinyan D, Suk Y, Uehling D, Saini M, Aman A, Magolan J, Subapanditha MK, McKenna D, Chokshi C, Savage N, Kameda-Smith MM, Venugopal C, Singh SK.
An effective kinase inhibition strategy for metastatic recurrent childhood medulloblastoma.
J Neurooncol. 2023 Jun 24∟. doi: 10.1007/s11060-023-04372-w∟. PMID: 37354357∟. Laboratory investigation˰ ˍ

Dos Santos ICL, da Silva Vargas Silva G, Murad LB, Murad LD.
Nutritional status and inflammatory markers as survival predictors in pediatric central nervous system tumors.
Clin Nutr ESPEN. 2023 Jun 24;57:89-95∟. doi: 10.1016/j.clnesp.2023.06.020∟. PMID: 37739738∟. Observational study. ˍ

Storozynsky QT, Han X, Komant S, Agopsowicz KC, Potts KG, Gamper AM, Godbout R, Evans DH, Hitt MM.
Radiation-Induced Cellular Senescence Reduces Susceptibility of Glioblastoma Cells to Oncolytic Vaccinia Virus.
Cancers (Basel). 2023 Jun 25;15(13):3341∟. doi: 10.3390/cancers15133341∟. PMID: 37444452∟. Laboratory investigation. ˍ

Galbraith K, Vasudevaraja V, Serrano J, Shen G, Tran I, Abdallat N, Wen M, Patel S, Movahed-Ezazi M, Faustin A, Spino-Keeton M, Roberts LG, Maloku E, Drexler SA, Liechty BL, Pisapia D, Krasnozhen-Ratush O, Rosenblum M, Shroff S, Boué DR, Davidson C, Mao Q, Suchi M, North P, Hopp A, Segura A, Jarzembowski JA, Parsons L, Johnson MD, Mobley B, Samore W, McGuone D, Gopal PP, Canoll PD, Horbinski C, Fullmer JM, Farooqui MS, Gokden M, Wadhwani NR, Richardson TE, Umphlett M, Tsankova NM, DeWitt JC, Sen C, Placantonakis DG, Pacione D, Wisoff JH, Teresa Hidalgo E, Harter D, William CM, Cordova C, Kurz SC, Barbaro M, Orringer DA, Karajannis MA, Sulman EP, Gardner SL, Zagzag D, Tsirigos A, Allen JC, Golfinos JG, Snuderl M.
Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing.
Neurooncol Adv. 2023 Jun 26;5(1):vdad076∟. doi: 10.1093/noajnl/vdad076∟. PMID: 37476329∟. Observational study. ˍ

Khatri NK, Kumar HS, Sharma N, Jakhar SL, Dhaka S.
Comparative study of concurrent conventional chemoradiotherapy versus hypofractionated chemoradiotherapy in newly diagnosed glioblastoma multiforme postoperative patients.
J Cancer Res Ther. 2023 Jun 26;19(5):1126-1130∟. doi: 10.4103/jcrt.jcrt_594_21∟. PMID: 37787273∟. Observational study. ˍ

Pan C, Zhang M, Xiao X, Kong L, Wu Y, Zhao X, Sun T, Zhang P, Geng Y, Zuo P, Wang Y, Li X, Gu G, Li T, Wu Z, Zhang J, Zhang L.
A multimodal imaging-based classification for pediatric diffuse intrinsic pontine gliomas.
Neurosurg Rev. 2023 Jun 26;46(1):151∟. doi: 10.1007/s10143-023-02068-3∟. PMID: 37358632∟. Observational study˰ ˍ

Cappelli L, Khan MM, Kayne A, Poiset S, Miller R, Ali A, Niazi M, Shi W, Alnahhas I.
Differences in clinical outcomes based on molecular markers in glioblastoma patients treated with concurrent tumor-treating fields and chemoradiation: exploratory analysis of the SPARE trial.
Chin Clin Oncol. 2023 Jun 27;12(3):23∟. doi: 10.21037/cco-22-123∟. PMID: 37417289∟. Interventional study∟. ˍ

Alaayedi MH, Maraie NK.
Lomustine's nanoemulsion as nose-to-brain drug delivery system for CNS tumor treatment.
Saudi Pharm J. 2023 Jun 28;31(8):101692∟. doi: 10.1016/j.jsps.2023.06.025∟. PMID: 37457367∟. Laboratory investigation. ˍ

Kolodziejczak AS, Guerrini-Rousseau L, Planchon JM, Ecker J, Selt F, Mynarek M, Obrecht D, Sill M, Autry RJ, Zhao E, Hirsch S, Amouyal E, Dufour C, Ayrault O, Torrejon J, Waszak SM, Ramaswamy V, Pentikainen V, Demir HA, Clifford SC, Schwalbe EC, Massimi L, Snuderl M, Galbraith K, Karajannis MA, Hill K, Li BK, Walsh M, White CL, Redmond S, Loizos L, Jakob M, Kordes UR, Schmid I, Hauer J, Blattmann C, Filippidou M, Piccolo G, Scheurlen W, Farrag A, Grund K, Sutter C, Pietsch T, Frank S, Schewe DM, Malkin D, Ben-Arush M, Sehested A, Wong TT, Wu KS, Liu YL, Carceller F, Mueller S, Stoller S, Taylor MD, Tabori U, Bouffet E, Kool M, Sahm F, von Deimling A, Korshunov A, von Hoff K, Kratz CP, Sturm D, Jones DTW, Rutkowski S, van Tilburg CM, Witt O, Bougeard G, Pajtler KW, Pfister SM, Bourdeaut F, Milde T.
Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.
Neuro Oncol. 2023 Jun 28:noad114∟. doi: 10.1093/neuonc/noad114∟. PMID: 37379234∟. Observational study˰ ˍ

Lee J, Nicosia M, Hong ES, Silver DJ, Li C, Bayik D, Watson DC, Lauko A, Kay KE, Wang SZ, Johnson S, McGraw M, Grabowski MM, Kish DD, Desai AB, Goodman WA, Cameron SJ, Okada H, Valujskikh A, Fairchild RL, Ahluwalia MS, Lathia JD.
Sex-Biased T-cell Exhaustion Drives Differential Immune Responses in Glioblastoma.
Cancer Discov. 2023 Jun 28;13(9):2090-2105∟. doi: 10.1158/2159-8290.CD-22-0869∟. PMID: 37378557∟. Laboratory investigation. ˍ

Li HB, Conte GM, Anwar SM, Kofler F, Ezhov I, van Leemput K, Piraud M, Diaz M, Cole B, Calabrese E, Rudie J, Meissen F, Adewole M, Janas A, Kazerooni AF, LaBella D, Moawad AW, Farahani K, Eddy J, Bergquist T, Chung V, Shinohara RT, Dako F, Wiggins W, Reitman Z, Wang C, Liu X, Jiang Z, Familiar A, Johanson E, Meier Z, Davatzikos C, Freymann J, Kirby J, Bilello M, Fathallah-Shaykh HM, Wiest R, Kirschke J, Colen RR, Kotrotsou A, Lamontagne P, Marcus D, Milchenko M, Nazeri A, Weber MA, Mahajan A, Mohan S, Mongan J, Hess C, Cha S, Villanueva J, Colak ME, Crivellaro P, Jakab A, Albrecht J, Anazodo U, Aboian M, Yu T, Chung V, Bergquist T, Eddy J, Albrecht J, Baid U, Bakas S, Linguraru MG, Menze B, Iglesias JE, Wiestler B.
The Brain Tumor Segmentation (BraTS) Challenge 2023: Brain MR Image Synthesis for Tumor Segmentation (BraSyn).
ArXiv [Preprint]. 2023 Jun 28:arXiv:2305.09011v5∟. PMID: 37608932∟. Observational study. ˍ

Yamada E, Ishikawa E, Miyazaki T, Miki S, Sugii N, Kohzuki H, Tsurubuchi T, Sakamoto N, Watanabe S, Matsuda M.
P53-negative status and gross total resection as predictive factors for autologous tumor vaccine treatment in newly diagnosed glioblastoma patients.
Neurooncol Adv. 2023 Jun 28;5(1):vdad079∟. doi: 10.1093/noajnl/vdad079∟. PMID: 37484760∟. Observational study. ˍ

He J, He S, Zhang Y, Tian Y, Hao P, Li T, Xiao Y, Peng L, Feng Y, Cheng X, Deng H, Wang P, Chong W, Hai Y, Chen L, You C, Jia L, Chen D, Fang F.
Association between intraoperative steroid and postoperative mortality in patients undergoing craniotomy for brain tumor.
Front Neurol. 2023 Jun 29;14:1153392∟. doi: 10.3389/fneur.2023.1153392∟. PMID: 37456646∟. Observational study. ˍ

*

Kamson DO, Puri S, Sang Y, Shi MJ, Blair L, Blakeley JO, Laterra J.
Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase (IDH) mutant Astrocytic and Oligodendroglial Tumors.
Clin Cancer Res. 2023 Jun 29:CCR-23-0585∟. doi: 10.1158/1078-0432.CCR-23-0585∟. PMID: 37382607∟. Observational study˰ ˍ

Oh TK, Park HY, Song IA.
Association between Preoperative Psychiatric Morbidities and Mortality after Oncologic Surgery: A Nationwide Cohort Study from 2002 to 2019 in South Korea.
J Pers Med. 2023 Jun 29;13(7):1069∟. doi: 10.3390/jpm13071069∟. PMID: 37511682∟. Observational study. ˍ

Park D, Doan N.
Non-enhancing Glioblastoma: A Case Report.
Cureus. 2023 Jun 29;15(6):e41153∟. doi: 10.7759/cureus.41153∟. PMID: 37519559∟. Case report. ˍ

Zanuttini L, Orsatti A, Martinoni M.
A peculiar case of pure intraventricular glioblastoma.
Neurol Sci. 2023 Jun 29∟. doi: 10.1007/s10072-023-06924-4∟. PMID: 37382731∟. Case report. ˍ

Cheng L, Duan W, Guan J, Wang K, Liu Z, Wang X, Wang Z, Wu H, Chen Z, Jian F.
Detection of Glioma-Related Hotspot Mutations Through Sequencing of Cerebrospinal Fluid (CSF)-Derived Circulating Tumor DNA: A Pilot Study on CSF-Based Liquid Biopsy for Primary Spinal Cord Astrocytoma.
Neurospine. 2023 Jun 30;20(2):701-708∟. doi: 10.14245/ns.2346210.105∟. PMID: 37401089∟. Observational study. ˍ

Haemmerli J, Sveikata L, Nouri A, May A, Egervari K, Freyschlag C, Lobrinus JA, Migliorini D, Momjian S, Sanda N, Schaller K, Tran S, Yeung J, Bijlenga P.
ChatGPT in glioma adjuvant therapy decision making: ready to assume the role of a doctor in the tumour board?
BMJ Health Care Inform. 2023 Jun 30;30(1):e100775∟. doi: 10.1136/bmjhci-2023-100775? PMID: 37399360∟. Observational study. ˍ

Liu Y, Gao D, Chen H, Zhang J, Yao K, Wu C, Li S, Yan W, Qiu X.
IDH-mutant grade 4 astrocytoma: a comparison integrating the clinical, pathological, and survival features between primary and secondary patients.
J Neurosurg. 2023 Jun 30:1-10∟. doi: 10.3171/2023.5.JNS222658∟. PMID: 37410628∟. Observational study˰ ˍ

Viozzi I, Neutel C, Overduin C, Ter Laan M.
Letter: Newly Diagnosed Adult Basal Ganglia Gliomas Treated With Laser Interstitial Thermal Therapy: A Comparative Cohort With Needle Biopsy.
Oper Neurosurg (Hagerstown). 2023 Jun 30∟. doi: 10.1227/ons.0000000000000820∟. PMID: 37387565∟. Letter, Observational study. ˍ